Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

NCT02646969 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 691

Last updated 2025-05-15

No results posted yet for this study

Summary

Growth and metabolic biomarkers of healthy term infants fed formulas with staged protein concentrations over the first year of life

Conditions

  • Healthy Term Infants

Interventions

DIETARY_SUPPLEMENT

Formula regimen 1

DIETARY_SUPPLEMENT

Formula regimen 2

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Sebastien Paoli, MSc · Nestlé Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02646969 on ClinicalTrials.gov